Academic Journal
FP03.03 ECOG PS of 0-1 and Very High PD-L1 Expression ≥90% Are Associated With Clinical Benefit From First-Line Chemo-Immunotherapy in Advanced NSCLC
العنوان: | FP03.03 ECOG PS of 0-1 and Very High PD-L1 Expression ≥90% Are Associated With Clinical Benefit From First-Line Chemo-Immunotherapy in Advanced NSCLC |
---|---|
المؤلفون: | Ricciuti, B., Alessi, J., Alden, S., Recondo, G., Nishino, M., Sholl, L., Awad, M. |
المصدر: | Journal of Thoracic Oncology ; volume 16, issue 10, page S948-S949 ; ISSN 1556-0864 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2021 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.jtho.2021.08.213 |
الاتاحة: | http://dx.doi.org/10.1016/j.jtho.2021.08.213 https://api.elsevier.com/content/article/PII:S1556086421026368?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S1556086421026368?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
رقم الانضمام: | edsbas.7CA129AA |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.jtho.2021.08.213 |
---|